Vagifem 10 μg Vaginal tablets
PDF Leaflet Revision Date: 03 December 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of atrophic vaginitis due to oestrogen deficiency.
Dosage (summary)
Initial: 1 tablet daily for 2 weeks; Maintenance: 1 tablet twice a week.
Special Populations
- Elderly
- Women with intact uterus
Pregnancy & Breastfeeding
Contraindicated during pregnancy and lactation.
Key Drug Interactions
- Anticonvulsants
- Anti-infectives
- St John's wort
Contraindications
- Breast cancer history
- Oestrogen-dependent tumors
- Undiagnosed genital bleeding
- DVT or PE history
- Active liver disease
Common side effects
- Vulvovaginal mycotic infection
- Vulvovaginal pruritus
- Breast pain
- Peripheral oedema
Counselling Points
- Perform monthly breast self-exams.
- Report any unusual bleeding.
- Avoid double dosing if a dose is missed.
Serious warnings
- Increased risk of breast cancer with prolonged use
- Risk of endometrial hyperplasia
- Monitor for thromboembolic events
Important Disclaimer
The Vagifem 10 μg Vaginal tablets professional information leaflet below is the property of Novo Nordisk and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
